| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/0886022X.2013.790298 |
| P698 | PubMed publication ID | 23650950 |
| P2093 | author name string | Kaan Okyay | |
| Haldun Muderrisoglu | |||
| Alp Aydinalp | |||
| Ayse Canan Yazici | |||
| Aylin Yıldırır | |||
| Suleyman Kanyilmaz | |||
| Mutlu Cicek | |||
| P2860 | cites work | Prophylaxis strategies for contrast-induced nephropathy | Q28247353 |
| Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). | Q34209991 | ||
| Epidemiology and prognostic implications of contrast-induced nephropathy | Q34570528 | ||
| Radiocontrast induced nephropathy. | Q35090111 | ||
| Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies | Q36136330 | ||
| Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention | Q36401491 | ||
| Contrast medium-induced nephropathy: the pathophysiology. | Q36448323 | ||
| Contrast medium use. | Q36584089 | ||
| Strategies to reduce the risk of contrast-induced nephropathy | Q36584094 | ||
| Alpha-lipoic acid supplementation and diabetes | Q37329377 | ||
| Contrast-induced nephropathy: pathogenesis and prevention | Q37483551 | ||
| Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis | Q37619895 | ||
| Angiotensin-converting enzyme inhibitors and their effects on contrast-induced nephropathy after cardiac catheterization or percutaneous coronary intervention | Q37855262 | ||
| New α-lipoic acid derivative, DHL-HisZn, ameliorates renal ischemia-reperfusion injury in rats | Q39578008 | ||
| Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease | Q42874057 | ||
| Cystatin C and contrast-induced acute kidney injury. | Q43075382 | ||
| Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. | Q43210226 | ||
| Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled study | Q43601956 | ||
| Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention | Q43993720 | ||
| Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial | Q44643934 | ||
| Pro-oxidant actions of alpha-lipoic acid and dihydrolipoic acid | Q46705618 | ||
| Alpha-lipoic acid protects against renal ischaemia-reperfusion injury in rats | Q46946118 | ||
| P433 | issue | 5 | |
| P921 | main subject | contrast-induced nephropathy | Q1783300 |
| P304 | page(s) | 748-753 | |
| P577 | publication date | 2013-05-07 | |
| P1433 | published in | Renal Failure | Q15762963 |
| P1476 | title | Use of alpha-lipoic acid in prevention of contrast-induced nephropathy in diabetic patients | |
| P478 | volume | 35 |
| Q34012029 | Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases |
| Q55619567 | Clinical Efficacy of Alprostadil Combined with α-lipoic Acid in the Treatment of Elderly Patients with Diabetic Nephropathy. |
| Q41889657 | Comparison of Carvedilol and Metoprolol for Preventing Contrast-Induced Nephropathy after Coronary Angiography |
| Q59127199 | Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis |
| Q37357860 | From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling |
| Q35805066 | Gastrointestinal Tract Commensal Bacteria and Probiotics: Influence on End-Organ Physiology |
| Q47099705 | Novel Therapies for Acute Kidney Injury |
Search more.